APA (7th ed.) Citation

LE, R., Y, B., JR, R., JJ, N., H, M., G, L., . . . M, N. (2025). Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC). Expert review of anticancer therapy, 25(6), 711. https://doi.org/10.1080/14737140.2025.2491648

Chicago Style (17th ed.) Citation

LE, Raez, et al. "Prevalence and Molecular Correlates of Acquired EGFR Resistance Mutations in Non-small Cell Lung Cancer (NSCLC)." Expert Review of Anticancer Therapy 25, no. 6 (2025): 711. https://doi.org/10.1080/14737140.2025.2491648.

MLA (9th ed.) Citation

LE, Raez, et al. "Prevalence and Molecular Correlates of Acquired EGFR Resistance Mutations in Non-small Cell Lung Cancer (NSCLC)." Expert Review of Anticancer Therapy, vol. 25, no. 6, 2025, p. 711, https://doi.org/10.1080/14737140.2025.2491648.